Yes, BB mentioned being placed with another Pharma company. I like this, if they assist in its development like AstraZeneca, you’d expect they’d then go on to roll out across their sites.
After reviewing all options, AZ decided to go with LBT’s technology and fund the APAS Pharma’s development
There are 600 manufacturing sites across 20 pharma companies.
Back on APAS Clinical, in addition to Urine and MRSA we should hopefully also have the AMR module ready soon. Keen to see if they’ve made further advancements with the early plate reading
LBT Price at posting:
3.5¢ Sentiment: None Disclosure: Held
